| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |